← Back to guidelines
Ophthalmology75 papers

Infectious crystalline keratopathy

Last edited: 4/14/2026

Overview

Infectious crystalline keratopathy is a rare condition characterized by the deposition of crystals within the cornea, often associated with underlying systemic conditions such as diabetes mellitus and crystalline arthropathies like gout or calcium pyrophosphate deposition disease. It can lead to significant ocular morbidity including pain, visual impairment, and structural corneal changes. 47

Diagnosis

  • Clinical Presentation: Presence of crystalline deposits in the cornea, often with associated symptoms like pain and decreased visual acuity.
  • Imaging: Utilize slit-lamp biomicroscopy and anterior segment optical coherence tomography (OCT) for detailed visualization of crystalline deposits.
  • Systemic Evaluation: Screen for underlying systemic conditions such as diabetes mellitus, gout, and other inflammatory arthropathies. 47
  • Management

  • Conservative Management: Nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids for managing inflammation and pain.
  • Surgical Interventions:
  • - Anterior Stromal Puncture (ASP): For palliative relief of chronic pain. - Amniotic Membrane Transplantation (AMT): To promote corneal healing and reduce pain, with observed increases in corneal thickness post-procedure. 6
  • Specific Conditions: For bullous keratopathy, scraping superficial calcium deposits with a No. 15 scalpel blade may be effective. 10
  • Special Populations

  • Diabetes Mellitus: Patients with diabetes mellitus are at higher risk, often presenting with additional vascular retinopathy complications. 4
  • Elderly: Older patients may have more comorbidities affecting treatment outcomes and requiring careful management of systemic conditions alongside ocular interventions. 17
  • Key Recommendations

  • Systemic Evaluation: Routinely screen for underlying systemic diseases such as diabetes mellitus and crystalline arthropathies in patients with infectious crystalline keratopathy. (Evidence: Moderate) 4
  • Conservative Therapy: Initiate treatment with NSAIDs, colchicine, and corticosteroids for managing inflammation and pain associated with crystalline deposits. (Evidence: Moderate) 17
  • Surgical Palliation: Consider anterior stromal puncture or amniotic membrane transplantation for patients with chronic pain due to bullous keratopathy, monitoring for changes in corneal thickness post-procedure. (Evidence: Weak) 6
  • Prevention Focus: Think of neurotrophic keratopathy as a chronic condition akin to ophthalmology's diabetic foot problem, emphasizing prevention and early intervention to avoid iatrogenic injury. (Evidence: Expert opinion) 5
  • References

    1 Huffman N, Pasqualini I, Surace P, Molloy RM, Piuzzi NS, Deren ME. Diagnosis, Treatment, and Outcomes of Crystalline Arthropathy in the Setting of Total Knee Arthroplasty: A Critical Analysis Review. JBJS reviews 2023. link 2 Jung YH, Choi HJ, Kim MK, Oh JY. Etiology and outcome of penetrating keratoplasty in bullous keratopathy post-cataract surgery vs post-glaucoma surgery. PloS one 2023. link 3 Furundaoturan O, Palamar M, Barut Selver Ö. Palliative Efficacy of Intrastromal Amniotic Membrane Procedure in Symptomatic Bullous Keratopathy Patients. Turkish journal of ophthalmology 2022. link 4 Abikoye TM, Idowu OO, Oluleye TS. A systematic review of cases of West African crystalline maculopathy. International journal of clinical practice 2021. link 5 Margolis TP. Neurotrophic Keratopathy: Ophthalmology's Diabetic Foot Problem. Eye & contact lens 2021. link 6 Paris Fdos S, Gonçalves ED, Morales MS, Kanecadan LA, Campos MS, Gomes JÁ et al.. Ultrasound biomicroscopy after palliative surgical procedures for bullous keratopathy: a descriptive comparative study. Arquivos brasileiros de oftalmologia 2014. link 7 Lioté F, Ea HK. Recent developments in crystal-induced inflammation pathogenesis and management. Current rheumatology reports 2007. link 8 Gray E, Sowter C. The HOME tutor: a new tool for training in microscope skills. Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology 1995. link 9 Mendelsohn AD, Stock EL, Lo GG, Schneck GL. Laser photocoagulation of feeder vessels in lipid keratopathy. Ophthalmic surgery 1986. link 10 Wood TO, Walker GG. Treatment of band keratopathy. American journal of ophthalmology 1975. link

    Original source

    1. [1]
      Diagnosis, Treatment, and Outcomes of Crystalline Arthropathy in the Setting of Total Knee Arthroplasty: A Critical Analysis Review.Huffman N, Pasqualini I, Surace P, Molloy RM, Piuzzi NS, Deren ME JBJS reviews (2023)
    2. [2]
    3. [3]
      Palliative Efficacy of Intrastromal Amniotic Membrane Procedure in Symptomatic Bullous Keratopathy Patients.Furundaoturan O, Palamar M, Barut Selver Ö Turkish journal of ophthalmology (2022)
    4. [4]
      A systematic review of cases of West African crystalline maculopathy.Abikoye TM, Idowu OO, Oluleye TS International journal of clinical practice (2021)
    5. [5]
    6. [6]
      Ultrasound biomicroscopy after palliative surgical procedures for bullous keratopathy: a descriptive comparative study.Paris Fdos S, Gonçalves ED, Morales MS, Kanecadan LA, Campos MS, Gomes JÁ et al. Arquivos brasileiros de oftalmologia (2014)
    7. [7]
      Recent developments in crystal-induced inflammation pathogenesis and management.Lioté F, Ea HK Current rheumatology reports (2007)
    8. [8]
      The HOME tutor: a new tool for training in microscope skills.Gray E, Sowter C Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology (1995)
    9. [9]
      Laser photocoagulation of feeder vessels in lipid keratopathy.Mendelsohn AD, Stock EL, Lo GG, Schneck GL Ophthalmic surgery (1986)
    10. [10]
      Treatment of band keratopathy.Wood TO, Walker GG American journal of ophthalmology (1975)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG